Home | Welcome to Contract Pharma   
Last Updated Thursday, May 28 2015

Print RSS Feed

Topics - APIs


Refine by Date:
From: To:
Published May 22, 2015
To provide aseptic and low bioburden clean room dispensing of bulk materials Read More »
Published May 12, 2015
To bolster clinical and commercial bulk drug production and fill/finish for gene therapies Read More »
Published May 11, 2015
The acquired business produces active pharmaceutical ingredients and intermediate products Read More »
Published May 5, 2015
Contract revenue up 47% in the quarter Read More »
Published April 14, 2015
Will partner to develop new compounds Read More »
Published April 6, 2015
Opens a 1600L/1000L reactor stream, increases throughput for 400L reactors Read More »
Published April 6, 2015
Activities will be transitioned to other facilities, affecting approx. 62 positions Read More »
Published March 30, 2015
Will install a new Class 100,000 suite at its North East England facility Read More »
Laurus Synthesis Launches US Operations
Published March 20, 2015
Opens facility in Woburn, MA Read More »
Published March 11, 2015
New site will offer fully integrated formulation development services Read More »
Published March 11, 2015
High containment site is in Edinburgh, UK and part of the Macfarlan Smith division Read More »
Published March 4, 2015
Expands API development and manufacturing capabilities Read More »
Published February 27, 2015
Will offer production of API using microbial expression systems Read More »
Published February 17, 2015
To provide custom biomanufacturing for commercial production Read More »
Published February 3, 2015
Expands custom chemical and biochemical manufacturing portfolio Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On